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Summary 
We have cloned a receptor, named LSCPR, for vaso- 
pressin-related Lys-conopressin in Lymnaea stag- 
nails. Lys-conopressin evokes Ca2+-dependent Ci- 
currents in Xenopus oocytes injected with LSCPR 
cRNA. Expression of LSCPR mRNA was detected in 
central neurons and peripheral muscles associated 
with reproduction. Upon application of Lys-conopres- 
sin, both neurons and muscle cells depolarize owing 
to an enhancement of voltage-dependent Ca 2+ cur- 
rents and start firing action potentials. Some neurons 
coexpress LSCPR and Lys-conopressin, suggesting 
an autotransmitter-like function for this peptide. Lys- 
conopressin also induces a depolarizing response in 
LSCPR-expressing neuroendocrine cells that control 
carbohydrate metabolism. Thus, in addition to oxyto- 
cin-like reproductive functions, LSCPR mediates vaso- 
pressin-like metabolic functions of Lys-conopressin 
as well. 
Introduction 
In mammals, the nonapeptides vasopressin and oxytocin 
have important functions in the control of osmoregulation 
and reproduction, respectively (reviewed in Cunningham 
and Sawchenko, 1991). These functions are mediated by 
pharmacologically distinct receptors (Jard et al., 1987). 
Recent cloning studies have shown that these receptors 
belong to a family of structurally related G protein-coupled 
receptors. The V2 vasopressin receptor mediates the anti- 
diuretic effects of vasopressin and couples positively to 
adenylate cyclase (Birnbaumer et al., 1992; Lolait et al., 
1992; Gorbulev et al., 1993). The Vla (Morel et al., 1992; 
§Present address: Universit&t Potsdam and Deutsches Institut for Er- 
n&hrungsforschung, Arthur-Scheunert-Allee 114-116, D-14558 Pots- 
dam-RehbrQcke, Germany. 
Thibonnier et al., 1994) and the Vl b (Sugimoto et al., 1994) 
vasopressin receptors, which mediate the effects of vaso- 
pressin on liver glycogenolysis and adenocorticotropin re- 
lease, respectively, as well as the oxytocin receptor (Ki- 
mura et al., 1992; Gorbulev et al., 1993), which mediates 
the various central and peripheral functions in reproduc- 
tion of oxytocin, all couple to the inositol trisphosphate 
(IP3)/Ca 2+ signal transduction pathway. Vasopressin and 
oxytocin are structurally and functionally distinguished by 
the chemical nature of the amino acid residues at position 
8. In vasopressin (and all peptides related to vasopressin), 
this residue is a basic residue, whereas in oxytocin (and 
all peptides related to oxytocin), it is a neutral, in most 
cases aliphatic, residue (see Acher, 1993, for review). Dis- 
tinct vasopressin and oxytocin lineages originate from the 
duplication of a single ancestral gene early during verte- 
brate evolution (Acher, 1980; Van Kesteren et al., 1995). 
However, the concomitant evolution of distinct classes of 
receptors for the two types of peptide, in particular the 
codevelopment of specificity determinants in the recep- 
tors, is poorly understood. Peptides and receptors of 
the vasopressin/oxytocin superfamily offer an attractive 
model for studies of the molecular basis of the specificity of 
peptide-receptor interactions, because specific receptor 
binding is mainly determined by the chemical nature of a 
single amino acid residue in the peptides (Sharif and Han- 
ley, 1992). It would be very useful, however, to have at 
our disposal an ancestral form of receptor that can be used 
as an experimental tool in the determination of specificity 
domains. 
In invertebrates, the vasopressin-related peptide Lys- 
conopressin is widely distributed throughout he different 
phyla (Cruz et al., 1987; McMaster et al., 1992; Salzet et 
al., 1993; Nielsen et al., 1994; Van Kesteren et al., 1995). 
Although oxytocin-related peptides have also been struc- 
turally identified in invertebrates (Reich, 1992; Oumi et al., 
1994), co-occu rrence of vasopressin- and oxytocin-related 
peptides has never been demonstrated in the same spe- 
cies. Moreover, the Lys-conopressin gene is the only mem- 
ber of the vasopressin/oxytocin gene superfamily present 
in the mollusc Lymnaea stagnalis (Van Kesteren et al., 
1995), which supports the hypothesis that the primordial 
gene duplication that gave rise to distinct vasopressin and 
oxytocin lineages occurred during vertebrate evolution 
and suggests that species variation and not gene duplica- 
tion explains the occurrence of both vasopressin- and oxy- 
tocin-related peptides in invertebrates. Lys-conopressin is 
synthesized by central neurons and functions as a neuro- 
transmitter/neuromodulator in both the brain and the male 
copulatory organs (Van Kesteren et al., 1995). It induces 
contractions of the vas deferens, thus stimulating the ejac- 
ulation of semen during copulation, and inhibits central 
neuroendocrine cells that coordinate female reproductive 
behavior. Thus, although structurally related to vasopres- 
sin, Lys-conopressin controls reproductive functions that 
are clearly analogous to the central and myoregulatory 
functions of oxytocin in vertebrate reproduction. 
Neuron 
898 
As these findings suggest that both vasopressin and 
oxytocin may have evolved from a Lys-conopressin-like 
ancestral peptide, the Lys-conopressin receptor may also 
display characteristics of an ancestral receptor that pre- 
ceded the vasopressin and the oxytocin receptor lineages 
in vertebrates. We have now structurally identified a recep- 
tor for Lys-conopressin. This receptor, named L. stagnalis 
conopressin receptor (LSCPR), is structurally related to 
both vasopressin and oxytocin receptors. Functional ex- 
pression in Xenopus laevis oocytes reveals that LSCPR 
is most likely coupled to the IP3/Ca 2+ signal transduction 
pathway, a characteristic that is shared with both V1 type 
vasopressin and oxytocin receptors. Moreover, the tissue 
and neuronal distribution of LSCPR, together with electro- 
physiological measurements of muscle cells and central 
neurons that express LSCPR, indicates that it mediates 
oxytocin-like reproductive functions as well as vasopres- 
sin-like metabolic functions of Lys-conopressin. 
Results 
Cloning of LSCPR 
PCR on vas deferens cDNA using primers TM6s and 
TM7as yielded mixtures of amplified cDNAs. When prod- 
ucts with the expected size of 150 bp were cloned into 
pBluescript and sequenced, four different cDNAs were 
found, all encoding putative G protein-coupled receptor 
fragments. Database searches revealed that one of the 
cloned cDNAs encoded a protein fragment having a signifi- 
cantly higher sequence identity with vasopressin and oxy- 
tocin receptors than with any other G protein-coupled re- 
ceptor. This fragment was used to screen brain-specific 
XZAPII cDNA libraries for full-length clones. Of 4 x 108 
independent clones that were screened, 1 hybridized and 
was isolated. The corresponding pBluescript phagemid, 
named pBSCPR, was rescued by in vivo excision and se- 
quenced, pBSCPR has an insert of 5.0 kb and contains 
an open reading frame of 1386 bp encoding a 462 amino 
acid protein with a predicted molecular mass of 52.2 kDa 
(Figure 1A). The open reading frame is preceded by an 
in-frame stop codon at position -57, which indicates that 
the coding region is complete at the 5' end. Although in- 
frame ATG sequences are also present at nucleotides 34 
and 40, the ATG at position I is suggested to be the transla- 
tion initiation site since it best fits the GCC(A/G)CCATGG 
Kozak consensus sequence for initiation of translation (Ko- 
zak, 1987). 
Structural Characteristics of LSCPR 
Hydrophobicity analysis (Kyte and Doolittle, 1982) of the 
predicted amino acid sequence revealed seven hydropho- 
bic domains characteristic for the seven transmembrane 
domains (TMs) of G protein-coupled receptors (Figure 1 B; 
Baldwin, 1993). Therefore, and because of its sequence 
identity with vasopressin and oxytocin receptors, the pre- 
dicted protein was tentatively named L. stagnalis cono- 
pressin receptor (LSCPR). LSCPR contains several poten- 
tial sites for N-linked glycosylation and for phosphorylation 
(Figure 1A). Consensus sequences for N-linked glycosyla- 
tion (Asn-X-Ser/Thr) occur predominantly in the extracellu- 
lar N-terminal domain and may have a function in targeting 
the receptor protein to the plasma membrane (Ostrowski 
et al., 1992) since the protein lacks a hydrophobic signal 
sequence. Consensus sequences for phosphorylation in- 
clude eight sites for protein kinase C (Ser/Thr-X-Arg/Lys) 
and four for casein kinase II (Ser/Thr-X-X-Asp/Glu) and 
occur predominantly in the third intracellular loop (be- 
tween TM5 and TM6) and in the C-terminus, suggesting 
that phosphorylation may be important in the modulation 
of G protein coupling and receptor function (Probst et al., 
1992). 
An amino acid sequence alignment of LSCPR and re- 
ceptors for vasopressin, oxytocin, and vasotocin from ver- 
tebrates is presented in Figure 2. In the region from the 
beginning of TM1 to the end of TM7, LSCPR has 43% 
sequence identity with the oxytocin receptor, the V la  and 
Vlb vasopressin receptors, and the vasotocin receptor 
and 39% sequence identity with the V2 vasopressin recep- 
tor. The N-terminal extracellular and the C-terminal intra- 
cellular domains of LSCPR are slightly longer than those 
of most vertebrate receptors. Also, the third intracellular 
loop is considerably longer, containing 26-40 amino acid 
residues more than the same loop in the various vertebrate 
receptors. Sequence identity is highest in the transmem- 
brahe domains, especially in TM7, whereas the N- and 
C-terminal domains as well as the third intracellular loop 
show hardly any sequence identity. 
In the first and second extracellular loops (between TM2 
and TM3 and between TM4 and TM5, respectively), sev- 
eral amino acid residues are found (Figure 2, asterisks) 
that are conserved among the members of the vasopres- 
sin/oxytocin receptor family in vertebrates but not in other 
G protein-coupled receptors. Since the two loops may be 
linked together by a disulphide bridge (Dohlman et al., 
1990) and form a putative ligand binding pocket, these 
residues are thought to be important in ligand binding 
(Sharif and Hanley, 1992). In LSCPR, these stretches of 
amino acid residues are conserved. The differences that 
are observed in the sequence PheGInValLeuProGInLeu 
at the end of TM2 involve conserved substitutions only 
(i.e., GInVal is replaced by Asnlle in LSCPR). However, 
in the sequences GlyProAsp and ProTrpGly (just before 
TM3 and TM5, respectively), the proline residues are both 
replaced by aspartate residues, introducing 2 additional 
negatively charged residues in the putative ligand binding 
pocket. In the sequence AspCysTrpAla (between TM4 and 
TM5), the tryptophane residue is replaced by a leucine 
residue. 
Another conserved sequence is located in the third intra- 
cellular loop just before TM6. This part of the receptor is 
known to be involved in G protean coupling (Ostrowski et 
al., 1992). Interestingly, the corresponding part in LSCPR 
has higher sequence identity with the oxytocin, V1 vaso- 
pressin, and vasotocin receptors, which are all coupled 
to the IPJCa 2+ signal transduction pathway, than with the 
V2 vasopressin receptor, which is coupled to adenylate 
cyclase. This may be indicative of the signal transduction 
characteristics of LSCPR. 
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ACCGAGTCCCACCTTTACACACTACACTATTGGAAGACCCCTGTCACTATC ATG GAT CTG GAG CTC AAC CTG ACC AAC GGG TTT ATG CTG ATG CCA 
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CCC ACC AAG CGG GCG GTC ATT CAG ATA GCG AGC AAC GAG AAG GTT GGC TAT GAC GTC AGC AAG AGC CAA CCC GTC AAC GCC ACG 
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Figure 1. The Primary Structure of LSCPR 
(A) Nucleotide sequence and deduced amino acid sequence of LSCPR eDNA. Only the open reading frame and a part of the 5' untranslated leader 
sequence are shown. Nucleotides and amino acids are numbered at the right, starting at the first ATG and the corresponding methionine residue. 
Nucleotides upstream from the first ATG are indicated with negative numbers. An in-frame stop codon at position -57  is underlined. Putative 
transmembrane domains in the predicted protein sequence are shown in reverse contrast. Putative sites for N-linked glycosylation (Asn-X-Ser/ 
Thr) are indicated by asterisks, and putative sites for phosphorylation by protein kinase C (SerFFhr-X-Arg/Lys) and casein kinase II (Serfrhr-X-X-Asp! 
Glu) are indicated by circles and triangles, respectively. 
(B) Hydrephobicity plot of the LSCPR protein according to Kyte and Doolittte (4982). Numbers below the figure indicate amine acid residue positions 
in the LSCPR protein. The seven hydrophobie regions that represent putative transmembrane domains are shown in black. 
Two adjacent cysteines that are found 15 residues 
downstream of TM7 in all the vertebrate vasopressin and 
oxytocin receptors identified so far may be responsible 
for anchoring the C-terminus to the plasma membrane 
through palmitoylation, as has been observed for the 
~-adrenergic receptor (O'Dowd et al., 1989). Since these 
cysteines are not present in LSCPR, its C-terminus is prob- 
ably not linked to the plasma membrane through a palmi- 
toylation anchor. 
Functional Expression of LSCPR 
in Xenopus Oocytes 
To demonstrate that LSCPR is a receptor for Lys-cono- 
pressin, we expressed the LSCPR cDNA in Xenopus oo- 
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TM I 
MDLELNLTNGFMLMP•TKRAVIQ IASNEKVGYDVSKSQPVNATTDLNTTRMNATNSTEVSYFHGVDEDLLK IE IAVQATILYMTLFGNGIVL  
MEGALAANWSAEAANASAAPPGAEGNRTAGPP- -RRNEALARVEVAVLCL ILLLALSGNACVL 
MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLE IAVLAVIFWAVLGNSSVL  
MDSGPLWDANPTPRGTLSAPNATTPWL- -GRDEELAKVEIGVLATVLVLATGGNLAVL 
MGRIANQTTASNDTDPF- - -GRNEEVAKMEITVLSVTFFVAVIGNLSVL  
MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLST IFVAVALSNGLVL  
TM II TM I I I  
LVL-RLRRQKL-TRMQWFIAHLAFADIFVGFFNILPQLISDVTIVFHGDD~TcRFIKYFQVIAMYA~SYVLVMAAIDRYLSICHPLTSQTLS 
LAL-RTTRQKH-SRLFFFMKHLs IADLwAVFQVLPQLLWDIT~RFYGPDLLcRLVXYLQWGMFA~T~LLLLMSLDRCLAICQPLRSLRRR 
LAL-HRTPRKT-SRMHLF IRHLSLADLAVAFFQVLPQLCWTSP-SFRGPDWLCRVVKHLQVFAMFA~AYMLVVMTADRYIAvcHPLKTLQQP 
LTL GQLGRKR-SRMHLFVLHLALTDLAVALFQvLPQLLWDITYRFQGPDLLCI~AVKYLQVLSMFA~T~MLLAMTLDRYLAVCHPLRSLQQP 
LA•-HNTKKKS-SRMHLF IKHLSLADM•fVAFFQVLPQLCWEITFRFYGPDFLcR IVKHLQVLGMFA•TYMMVMMTLDRYIA ICHPLKTLQQP 
GAL IRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALC~vKYLQMVG~p/ASS~ILAMTLDRHRAICRPMLAYRHG 
*******  . *** 
TM IV TM V 
PKRV-HLMIALAWLISFLCALPQVF IFSLQAVGPD - - -QYDCLATFEPDWGMQAYI~IVFVANYVIPFLLLAFCYGRICHVVWMSVAAKES 
TD - RLAVLATWLGCLVASAPQVHIFSLREVADG . . . .  VFDCWAVFIQPWGPKAYI~ITLAVY IVPV IVLATCYGL ISFK IWQNLRLKTA 
ARRS RLM•ATSWVLSF ILSTPQYF IFSV IE IEvNNGTKTQDCWATF IQPWGTRA¥VTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTA 
GQST-YLL IAAPWLLAAIFSLPQVF•FSLREVIQGSG- -VLD•WADFGFPWGPRAYLTWTTLA•FVLPVTMLTACYSL ICHEICKNLKVKTQ 
TQRA Y IMIGSTWLCSLLLSTPQYF IFSLSE IQNGSY -VYDCWGHFIEPWGIRAY ITWITVGIFL IPV I I LMICYGF ICHSIWKNIKCKTM 
GGARWNRPVLVAWAFSLLLSLPQLF IFAQRDVGNGSG- -VFDCWARFAEPWGLRAYVTWIALMV~VAPALGIAACQVL IFRE IHASLVPG 
**** . *** 
TM VI  
AAYSSMRNGCTESSRP IKMRISFHRRRDNTNATLTSLDRHDASAVTSSDSKKPRGHQRGVSKSKMKTIKLTLTvVLCYLFCWAPFFwQMWS 
A . . . . . . . . . . . . . . . .  AAAAEAPEGAAAGDGGRVALARVSSVKL ISKAKIRTVKMTF I IVLAF IVCWTPFFFVQMWS 
S . . . . . . . . . . . . . . .  SRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAY ILCWAPFF IVQMWS 
A . . . . . . . . . . . . . . . . .  WRVGGGGWRTWDRPSPSTLAATTRGLPSRVSSINT ISRAKIRTVKMTFVIVLAY IACWAPFFSVQMWS 
. . . . . . . . . . . . . . . . . . . . .  RGTRNTKDGMIGKVSVSSVT I ISRAKLRTVKMTLVIVLAY IVCWAPFF IVQMWS 
. . . . . . . . . . . . . . . . . . . . . . .  PSERAGTPQRAPDRSPSEGAHVSAAMAKTVRMTLVIV IVYVLCWAPFFLVQLWA 
TM VI I  
AFDDD- - -SGIEHPVTVICMLLASLN••T•PWIYLAFSGRTCQRNHANRNTSRSWGPSTHVTSGGDSHEFKTRSSF•DLSHARMNARSSSPR 
VWDAN-  APKEASAF I IVMLLASLNSC•NPWIYMLFTGHLFHELVQRFLCCSASYLKGRRLGETSASKKSNSSSFVLSHRSSSQRSCSQPS 
VWDENFIWTDSENPSIT ITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRKTDFLF  
VWDKNAPDEDSTNVAFT ISMLLGNLN•CCNP• IYMGFNSHLLPRPLRHLACCGGPQPRMRRRLSDGSLSSRHTTLLTRSSC•ATLSLSLSLT  
VWDENFSWDDSENAAVTLSALLASLNSCCNPWIYMLFSGHLLYDFLRCFPCCKKPRNMLQKEDSDSSIRRNTLLTKLAAGRMTNDGFGSWRD 
AWDPE- -  APLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSE LRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS 
LSCPRI  
HSOTR 
RNAVIa  
HSAVIb  
CCVTR 
RNAV2 
FSEMNKLNHSKC 
TA 
LSGRPRPEESPRDLELADGEGTAET I IF  
PCNSRKSSQSIGLDCFCKSSQCLEHDCSRKSSQCIPLbCSRKSSQCIPLDCSRKSSQCMSKES 
Figure 2. Alignment of the Amino Acid Sequences of LSCPR and Members of the Vasopressin/Oxytocin Receptor Family 
The amino acid sequence of LSCPR is aligned with those of the human oxytocin receptor (HSOTR; Kimura et al., 1992), the rat Vla vasopressin 
receptor (RNAVla; Morel et al., 1992), the h uman V1 b vasopressin receptor (H SAV1 b; Sugimoto et al., 1994), the vasotocin receptor of the teleost 
fish Catostomus commersoni (CCV[R; Mahlmann et al., 1994), and the rat V2 vasopressin receptor (RNAV2; Lolait et al., 1992). Amino acid 
residues that are identical in all receptor proteins are shown in boldface. Asterisks indicate amino acid residues that are highly conserved in the 
vertebrate vasopressin/oxytocin receptor family, but not in other G protein-coupled receptors, and have been suggested to be important in receptor- 
ligand interaction (Sharif and Hanley, 1992). Bars indicate the seven putative transmembrane domains. 
cytes by injection of cRNA and studied the response of 
injected oocytes upon application of Lys-conopressin and 
related peptides. To improve cRNA stability and expres- 
sion levels in Xenopus oocytes, the open reading frame 
of LSCPR was cloned in pGEMHE, between the 5' and 
3' untranslated sequences of the Xenopus 13-globin gene 
(Liman et al., 1992). Voltage-clamped oocytes that were 
previously injected with 5' capped cRNA derived from this 
construct responded to application of Lys-conopressin by 
displaying inward membrane currents (Figure 3A). To con- 
struct a dose-response curve, the mean responses of 
three independent experiments were plotted semilogarith- 
mically versus the concentrations of Lys-conopressin ap- 
plied (Figure 3B). The ECs0 value calculated from the three 
independent experiments was 22 + 2 nM (mean + SD), 
which is in good agreement with the ECs0 values observed 
for the human oxytocin receptor and the fish vasotocin 
receptor, which were also expressed in Xenopus oocytes 
(Kimura et al., 1992; Mahlmann et al., 1994). Ile-conopressin 
and Arg-conopressin were about 10 times less potent. The 
order of potency of all peptides tested is shown in Fig- 
ure 3C. 
Localization of LSCPR Gene Expression 
Because LSCPR mRNA levels were very low and undetect- 
able on Northern blots containing 4-10 #g of poly(A) + RNA 
from vas deferens or brain (data not shown), we applied 
reverse transcription polymerase chain reaction (RT- 
PCR) to determine whether the LSCPR gene is expressed 
in different organs that are involved in reproduction (male 
and female reproductive tracts) and osmoregulation 
(heart, kidney, and skin) and in the brain. To rule out the 
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Figure 3. Functional Expression of LSCPR in Xenopus Oocytes 
(A) Membrane current trace of an oocyte expressing the LSCPR pro- 
tein and being exposed to 5 x 10 -8 M Lys-conopressin (indicated by 
a bar). The initial fast inward current was typically followed by an 
oscillatory current, which is probably driven by intracellutar Ca 2+ oscil- 
lations and lasted for about 5 min after washing out of the peptide. 
(B) Dose-response curve of the effect of Lys-conopressin on the total 
membrane current. The total membrane currents elicited by 1.5 min 
applications of Lys-conopressin at different concentrations were inte- 
grated over time and plotted semilogarithmically versus the peptide 
concentration. The mean of three independent experiments is shown 
with SEM (error bars), and the ECs0 was calculated as 22 _+ 2 nM 
(mean -4- SD). 
(C) Pharmacological characterization ofLSCPR. Various vasopressin- 
and oxytocin-retated peptides are listed in order of potency in eliciting 
membrane current responses in Xenopus oocytes expressing LSCPR. 
For the conopressins, estimated EC~0 values are indicated; for the less 
potent peptides, the threshold concentrations for receptor activation 
are indicated. Arg-vasopressin and isotocin are inactive. 
possibility of detecting contaminant mRNA or cDNA, the 
experiment was performed in triplicate. Since we estab- 
lished the presence of an intron within the amplified se- 
quence (data not shown), amplification of genomic DNA 
would have been noted, but did not occur. LSCPR mRNA 
is present in the vas deferens and the brain, but not in 
the other tissues mentioned (Figure 4A). Interestingly, the 
amount of cDNA amplified from the anterior part of the 
vas deferens is higher than the amount from the posterior 
part of the vas deferens, suggesting a difference in the 
amount of LSCPR mRNA present in the two parts of the 
vas deferens. 
The localization of LSCPR mRNA in the brain was further 
investigated by in situ hybridization. One series of alter- 
nately collected sections of the brain was hybridized with a 
full-length LSCPR-specific antisense cRNA probe. LSCPR 
gene expression was detected in a number, but not all, 
of the neurons in the anterior lobes of the cerebral ganglia 
(Figures 4C and 4E). Since the anterior lobe neurons also 
express the Lys-conopressin gene (Van Kesteren et al., 
1995), alternate sections were hybridized with a Lys- 
conopressin-specific antisense cRNA probe in order to 
establish possible coexpression of LSCPR and Lys- 
conopressin. Indeed, most of the neurons that express 
LSCPR express also Lys-conopressin; however, a few 
cells express exclusively LSCPR or Lys-conopressin (Fig- 
ures 4B and 4D). LSCPR gene expression could also be 
detected in a few neurons in the pedal Ib cluster in the 
right pedal ganglion (Figure 4F) and in some of the cerebral 
light green cells (Figure 4G). In addition, several unidenti- 
fied neurons throughout the brain were found to express 
the LSCPR gene (data not shown). Control hybridizations 
with sense cRNA probes were all negative. 
In the vas deferens, we failed to localize LSCPR gene 
expression by in situ hybridization. This might be due to 
a low expression level of the LSCPR mRNA in all muscle 
cells; in the brain, expression levels in individual cells 
might be higher, but expression is restricted to a small 
number of neurons. Furthermore, diffusion of the mRNA 
throughout the cytoplasm of the muscle cells, which are 
much larger than neurons, may have caused the hybridiza- 
tion signal to drop below the detection level. 
Effects of Conopressin on Isolated Vas Deferens 
Muscle Cells, Anterior Lobe Cells, and 
Light Green Cells 
To establish the presence of LSCPR on muscle cells of 
the vas deferens and to study the functional role of these 
receptors, we measured the electrophysiological effects 
of Lys-conopressin on muscle cells in vitro. In these experi- 
ments, dissociated muscle cells of the anterior and poste- 
rior vas deferens were studied separately, since these 
parts seem to express the LSCPR gene at different levels. 
Under current clamp, muscle cells from the anterior part 
responded to a 5 s application of Lys-conopressin at 10 -5 
M (n = 4) with a slow, depolarizing potential lasting at 
least as long as the application. This depolarization gave 
rise to one or more all or none muscle spikes with a fast 
upstroke and decay, about 50 mV in amplitude and lasting 
2-3 s at half amplitude (Figure 5A). In two cells, the slow 
depolarization strongly outlasted the application and 
evoked several muscle spikes or plateau potentials of up 
to 10 s duration (Figure 5B). In cells from the posterior 
vas deferens, we observed only a small depolarization, 
which failed to induce muscle spikes (Figure 5C). 
The responses were investigated further under whole- 
cell voltage clamp. Under control conditions, cells of the 
anterior vas deferens revealed a time- and voltage-de- 
pendent response upon step depolarizations. This re- 
sponse consisted of a small, initial inward current followed 
by a much larger outward current (Figure 6A). The outward 
current was biphasic, suggesting that it consisted of at 
least two different K + currents. Inward currents were ob- 
served from -60  to -10  mV, and outward currents ap- 
peared at voltages of t>-20 inV. Lys-conopressin (applied 
at 10 -s M; n = 4) induced multiple changes in these volt- 
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Figure 4. Localization of LSCPR Gene Ex- 
pression 
(A) Tissue distribution of LSCPR as determined 
by RT-PCR. LSCPR expression was analyzed 
in the brain (lane 1), penis complex (lane 2), 
anterior vas deferens (lane 3), posterior vas 
deferens (lane 4), prostate gland (lane 5), 
spermoviduct (lane 6), ovotestis (lane 7), albu- 
men gland (lane 8), oothecal gland (lane 9), 
muciparous gland (lane 10), kidney (lane 11), 
skin (lane 12), salivary gland (lane 13), and hep- 
atopancreas (lane 14). Only in the brain and in 
the vas deferens could the LSCPR transcript 
could be detected. The amount of transcript 
detected in the posterior vas deferens was less 
than in the anterior vas deferens. Lane 15 con- 
tains a PCR product derived from the LSCPR 
clone and serves as a positive control for the 
PCR and the hybridization procedure. 
(B-E) In situ hybridization ofalternate sections 
through the anterior lobe of the right cerebral 
ganglion with the LSCPR cRNA probe (C and 
E) and with the Lys-conopressin cRNA probe 
(B and D). Black arrows indicate some of the 
neurons that express both LSCPR and Lys- 
conopressin. Open arrows in (B) and (C) indi- 
cate neurons that express Lys-conopressin but 
not LSCPR, and open arrows in (D) and (E) indi- 
cate neurons that express LSCPR but not Lys- 
conopressin. 
(F) In situ hybridization of a section through 
the pedal Ib cluster of the right pedal ganglion 
showing a single neuron that expresses the 
LSCPR gene (closed arrow). 
(G) In situ hybridization of a section through 
the right cerebral ganglion showing some light 
green cells that express the LSCPR gene 
(closed arrows). 
Bars, 50 #m. 
age-dependent currents (Figures 6B and 6C). First, it in- 
creased the inward current and extended its voltage range 
to +30 mV (Figure 6B). Difference plots obtained by sub- 
traction of control traces from responses in the presence of 
Lys-conopressin revealed that Lys-conopressin induced 
a new inward current component with fast apparent ki- 
netics of activation and inactivation. In addition, Lys- 
conopressin increased the initial, fast outward current 
(Figure 6C). The effects of Lys-conopressin on the slow 
outward current varied between cells. Both an increase 
and a decrease in the amplitude of this current were ob- 
served (data not shown), whereas in some cells, its ampli- 
tude was not affected (Figure 6C). This variabil ity suggests 
that the net effects on the slow outward current are due 
to changes in more than one current, possibly a Ca ~+ cur- 
rent and a Ca2+-dependent K + current. To investigate the 
possible contribution of a Ca 2+ current to the Lys-cono- 
pressin-induced changes in the total membrane current, 
we studied the effects of Lys-conopressin on the isolated 
Ca 2+ current. Under control conditions, this current con- 
sisted of a low voltage-activated, transient component (ac- 
tivation at >t-40 mV) with fast kinetics of inactivation and 
a high voltage-act ivated component (activation at >/-10 
mY) that inactivated more slowly (Figure 7A). Lys- 
conopressin (applied at 10 5 M; n = 2) strongly increased 
the amplitude of the high voltage-act ivated component 
without affecting its kinetics or voltage dependence (Fig- 
ures 7B and 7C). 
Cells of the posterior vas deferens under voltage clamp 
were not affected by Lys-conopressin. Neither the inward 
nor the outward current changed in amplitude when Lys- 
conopressin was applied (n = 4). Together, these findings 
strongly suggest that only muscle cells of the anterior vas 
deferens, and not those of the posterior vas deferens, ex- 
press LSCPR, which may explain the difference in the 
amounts of LSCPR cDNA that could be amplified from the 
two parts of the vas deferens. 
In addition to vas deferens muscle cells, we studied the 
effect of Lys-conopressin on central neurons that express 
the LSCPR gene. Light green cells and neurons in the right 
anterior lobe were recorded under current clamp. In light 
green cells in primary cell culture, Lys-conopressin (ap- 
plied at 10 e M for 5 s; n = 3) induced a depolarizing 
response that triggered a burst of action potential activity 
that lasted for -30  s (see Figure 5D). Neurons in the right 
anterior lobe were recorded in situ, in the isolated nervous 
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Figure 5. Membrane Potential Effects of Lys-Conopressin on Muscle Cells and Neurons 
(A and B) Excitatory responses of dissociated muscle cells from the anterior vas deferens to Lys-conopressin. Lys-conopressin (applied at t0 -5 
M for 5 s; arrow) elicits a slow depolarization that gives rise to all or none muscle spikes. In (B), several plateau potentials were also observed. 
(C) Response of a dissociated posterior vas deferens muscle cell to Lys-conopressin. In these cells, Lys-conopressin (applied at 10 5 M for 5 s; 
arrow) induces a weak depolarization but fails to elicit muscle spikes. 
(D) Excitatory response of a dissociated neuronal light green cell to Lys-conopressin. Lys-conopressin (applied at 10 6 M for 5 s; arrow) induces 
a depolarization that triggers a short burst of action potentials. 
(E) Excitatory response of an identified neuron in the anterior lobe of the right cerebral ganglion to Lys..conopressin. Here, Lys-conopressin (applied 
at 10 -s M for 20 s; arrow) induces a depolarization that triggers a burst of action potentials that lasts for -5  min (only partly shown). This cell was 
recorded in situ, in the isolated nervous system. 
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Figure 6. Whole-Cell Voltage-Clamp Recordings of the Total Current of a Dissociated Anterior Vas Deferens Muscle Cell 
Upper panels show current responses at command potentials ranging from -40 to 0 mV; holding potential was -80 mV. Lower panels show the 
complete current-voltage relations of the maximal inward (circles) and outward (triangles) currents. 
(A) Control currents showing a small and slow inward current, followed by a much larger, biphasic outward current. At potentials of >/-10 mV, no 
inward currents were observed. 
(B) In the presence of 10 5 M Lys-conopressin, a fast inward current appears at >/-10 mV. In addition, the initial fast outward current is increased. 
This cell revealed no change in the slow outward current. 
(C) Subtraction of control currents from responses in the presence of Lys-conopressin yields the Lys-conopressin-induced currents. 
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Figure 7. Whole-Cell Voltage-Clamp Recordings of the Isolated Ca 2+ Current of a Dissociated Anterior Vas Deferens Muscle Cell 
Upper panels show current responses at command potentials ranging from -60 to +40 mV; holding potential -80 rnV. Lower panels show the 
complete current-voltage relations of the maximal (circles) and the late (triangles) inward currents. Late currents were measured 250 ms after 
onset of the command potential. 
(A) Control currents showing a low voltage-activated component with fast kinetics of inactivation and a high voltage-activated component hat 
slowly inactivates. 
(B) In the presence of 10 -5 M Lys-conopressin, the amplitude of the high voltage-activated component is increased, whereas its voltage dependence 
and kinetics are not changed. 
(C) Subtraction of control currents from responses in the presence of Lys-conopressin yields the Lys-conopressin-induced Ca 2~ current. 
system. Some of these cells responded to 20 s applica- 
tions of Lys-conopressin (at 10 -~ M) with a depolarization 
followed by a burst of action potential activity that lasted 
for -5  min (see Figure 5E). Three anterior lobe neurons 
were positive in all five preparations tested. All responses 
were completely reversed when application was stopped 
and could be repeated several times. 
Discuss ion  
LSCPR Shares  St ructura l  and  S igna l  T ransduct ion  
Character i s t i cs  with both  Vasopress in  and 
Oxytoc in  Receptors  
In a previous study (Van Kesteren et al., 1995), we demon- 
strated that, although Lys-conopressin is structurally re- 
lated to vasopressin, it has functional characteristics that 
are usually associated with oxytocin. The aim of the pres- 
ent study is to clone the Lys-conopressin receptor and to 
characterize it structurally as well as functionally in order 
to gain insight into the evolution of functionally distinct 
vasopressin and oxytocin lineages. We used degenerate 
oligonucleotides directed to conserved sequences in re- 
cently cloned vasopressin and oxytocin receptors (Birn- 
baumer et a l ,  1992; Kimura et al., 1992; Lolait et al., 1992; 
Morel et al., 1992; Gorbulev et al., 1993; Sugimoto et al., 
1994; Thibonnier et al., 1994) to amplify similar sequences 
from Lymnaea vas deferens cDNA. One of the amplifica- 
tion products did have the expected size and exhibited a 
high degree of sequence identity with both vasopressin 
and oxytocin receptor sequences. This fragment was used 
to isolate a full-length cDNA clone. Hydrophobicity analy- 
sis of the predicted LSCPR protein revealed seven hy- 
dr•phobic regions similar to the seven transmembrane 
domains found in all members of the G protein-coupled 
receptor superfamily. Several lines of evidence indicate 
that LSCPR is a functional Lys-conopressin receptor and a 
member of the vasopressin/oxytocin receptor family. First, 
the overall sequence identity of LSCPR is higher with 
the vasopressin and oxytocin receptors than with any 
other G protein-coupled receptor. Second, conserved se- 
quences in the first and second extracellular loops of the 
vasopressin and oxytocin receptors that have been sug- 
gested to be involved in ligand binding (Sharif and Hanley, 
1992) are present in LSCPR. Third, the tissue distribution 
of LSCPR is in good agreement with earlier observed func- 
tions of Lys-conopressin in the control of male sexual be- 
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havior (Van Kesteren et al., 1995). Fourth, at physiological 
concentrations only Lys-conopressin activates LSCPR 
when functionally expressed in Xenopus oocytes, whereas 
other vasopressin- and oxytocin-related peptides do so 
only at higher concentrations or not at all. 
The LSCPR protein has the highest sequence identity 
with the V la  and Vlb vasopressin receptors and with the 
oxytocin receptor from mammals, as well as with the vaso- 
tocin receptor from teleost fish (see Figure 2), which all 
couple to the IP3/Ca 2+ signaling pathway. Sequence iden- 
tity is lower with the V2 vasopressin receptor, which cou- 
ples to adenylate cyclase and specifically mediates the 
antidiuretic effects of vasopressin in mammals. Assuming 
that these observations are indicative for the signal trans- 
duction characteristics of LSCPR, we expressed LSCPR 
in Xenopus oocytes, which respond to an increase in in- 
tracellular Ca 2÷ concentrations by displaying an inward 
membrane CI- current. This response is characteristic for 
receptors that activate the IP3/Ca 2+ signal transduction 
pathway (Meyerhof et al., 1988). Oocytes injected with 
LSCPR cRNA respond to application of Lys-conopressin 
with a fast increase in intracellular Ca 2+ levels, followed 
by Ca 2+ oscillations that last for about 5 min after washing 
out of the ligand. Vasopressin elicits a similar intracellular 
Ca 2+ response in oocytes expressing the V1 a vasopressin 
receptor (Nathanson et al., 1992). This response involves 
the mobilization of Ca 2+ from IP3-sensitive intracellular 
stores. Based on our observations and in analogy with the 
V la  vasopressin receptor, we conclude that LSCPR most 
likely couples to the IP3/Ca 2+ signal transduction pathway. 
LSCPR Is Selectively Activated by Lys-Conopressin 
We pharmacologically characterized LSCPR by studying 
the potencies of vasopressin- and oxytocin-related pep- 
tides in eliciting membrane current responses in Xenopus 
oocytes expressing the LSCPR protein (see Figure 3C). 
The three most potent peptides are the conopressins, indi- 
cating that the arginine residue at position 4 of these 
peptides, which is the only structural characteristic that 
distinguishes the conopressins from their vertebrate coun- 
terparts, is probably important in peptide-receptor interac- 
tion. Interestingly, the putative ligand binding pocket in 
LSCPR contains 2 negatively charged aspartate residues 
that are not found in the vertebrate receptors (see Figure 
2). Either of these may be important in binding the posi- 
tively charged arginine residue in the conopressins. From 
the order of potency of the other vasopressin- and oxyto- 
cin-related peptides, several constraints on amino acid 
residues 2-4 can be inferred. At position 2, the presence 
of an aromatic amino acid residue seems to be important, 
since Arg-conopressin, which contains an isoleucine resi- 
due at this position, is 10 times less potent than Lys- 
conopressin. At position 3, a nonaromatic hydrophobic 
residue is preferred, since Arg-vasopressin, which has a 
phenylalanine residue at this position, is inactive. At posi- 
tion 4, glutamine, but not serine, can replace the arginine 
residue to some extent, indicating the importance of a 
free amide group at this position. Thus, conformational 
flexibility in the N-terminal ring (residues 1-6) seems to be 
limited, and therefore this part of the molecule is probably 
involved in high affinity binding to the receptor. 
In vasopressin and oxytocin, the C-terminal part of the 
peptide, in particular esidue 8, is thought to be responsi- 
ble for the discriminative binding of the peptides to their 
respective receptors (Acher, 1993). We have previously 
predicted the presence of a Lys-conopressin receptor that 
is nondiscriminative with respect to residue 8 (Van Kest- 
eren et al., 1995), since Lys-conopressin and Ile-cono- 
pressin, an oxytocin-like analog of Lys-conopressin with 
the lysine residue at position 8 substituted with isoleucine, 
have similar bioactive potencies. Interestingly, LSCPR dis- 
plays discriminative binding of Lys-conopressin and lle- 
conopressin (see Figure 3C), suggesting that an addi- 
tional, nondiscriminative receptor subtype may exist in 
Lymnaea. 
LSCPR Mediates both Vasopressin- and 
Oxytocin-like Functions of Lys-Conopressin 
The LSCPR mRNA is predominantly present in tissues 
and central neurons that are involved in male copulatory 
behavior (i.e., the vas deferens [see Figure 4A], neurons 
of the anterior lobe of the right cerebral ganglion [see Fig- 
ures 4C and 4E], and neurons of the pedal Ib cluster [see 
Figure 4F]), suggesting a major role for LSCPR in the con- 
trol of male reproductive behavior. To understand the func- 
tional role of LSCPR in the control of vas deferens ac- 
tivities, we tested the electrophysiological effects of Lys- 
conopressin on smooth muscle cells from either the ante- 
rior or posterior part of the vas deferens in primary cell 
culture& Interestingly, muscle cells from the anterior part 
responded much more strongly to Lys-conopressin than 
muscle cells of the posterior part (see Figures 5A and 5B). 
Cells of the anterior part strongly depolarized and fired 
several action potentials in response to single applications 
of Lys-conopressin. Whole-cell voltage-clamp experiments 
revealed that this response is the result of changes in 
several voltage-dependent currents (see Figure 6). Most 
prominently, Lys-conopressin strongly enhanced the volt- 
age-dependent Ca 2+ current (see Figure 7). The increase 
in outward current observed in some preparations proba- 
bly results from the stimulation of a Ca2+-dependent K+ 
current caused by the increased inward Ca 2÷ current. 
Whether the appearance of a fast, transient inward current 
in the total current measurements (see Figure 6) is com- 
pletely caused by the increase in Ca 2+ current is unclear. 
Possibly, an increase in a different inward current, e.g., 
a Na + current, contributes to this response as well. Also, 
further experiments are needed to demonstrate that the 
Lys-conopressin-induced changes in voltage-dependent 
currents are all caused by the presumed activation of the 
IP3/Ca 2÷ signal transduction pathway and the concomitant 
activation of protein kinase C. In contrast to the muscle 
cells of the anterior vas deferens, cells of the posterior 
vas deferens were only slightly depolarized by Lys- 
conopressin. Under voltage clamp, no Lys-conopressin- 
induced changes were observed, in neither voltage- 
dependent nor -independent currents. 
These findings strongly suggest that LSCPR is exclu- 
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sively expressed on the cell surface of smooth muscle 
cells from the anterior part of the vas deferens. Since in 
vitro preparations of both parts of the vas deferens are 
equally responsive to Lys-conopressin (Van Golen et al., 
1995), we hypothesize that in the posterior part Lys- 
conopressin most likely modulates the release of other 
excitatory transmitters through an interaction with presyn- 
aptically expressed Lys-conopressin receptors. The small 
amount of LSCPR cDNA amplif ied from the posterior part 
may be derived from mRNA that has diffused into the axo- 
nal compartment of the neurons that express these pre- 
synaptic receptors. These neurons are probably the neu- 
rons of the anterior lobe and the pedal Ib cluster mentioned 
above, since they project into the penis nerve and inner- 
vate the male copulatory organs (Smit et al., 1992), includ- 
ing the vas deferens (Van Kesteren et al., 1995). 
Lys-conopressin also has a strong excitatory effect on 
neurons in the right anterior lobe (see Figure 5E). Some, 
but not all, of the cells responded to application of Lys- 
conopressin with a short burst of action potentials, which 
is in good agreement with the fact that not all cells in the 
lobe express the LSCPR gene (see Figures 4C and 4E). 
Because the majority of the anterior lobe cells that express 
LSCPR also express Lys-conopressin (see Figures 4B and 
4D), we suggest that Lys-conopressin acts as an excitatory 
autotransmitter on these cells and may play a role in the 
generation of electrical discharge activity in these cells. 
Similarly, autotransmitter-l ike functions have been re- 
ported for both oxytocin (Moos and Richard, 1989) and 
vasopressin (Wotjak et al., 1994) on magnocellular neu- 
rons in the rat. 
In addition to the different types of neurons involved in 
the control of reproductive behavior, some of the neuroen- 
docrine light green cells express the LSCPR gene. These 
cells synthesize and release insulin-related peptides (Smit 
et al., 1988; Li et al., 1992), which control somatic growth 
and glycogen metabolism in Lymnaea (Geraerts, 1992). 
Lys-conopressin induces a depolarizing response that trig- 
gers action potential firing in isolated light green cells (see 
Figure 5D), indicating that it may stimulate the release of 
insulin-related peptides. Preliminary experiments indicate 
that, as in anterior vas deferens muscle cells, enhance- 
ment of the voltage-dependent Ca 2÷ current is involved in 
this response. Interestingly, vasopressin stimulates the 
release of insulin from pancreatic ~ cells in the rat (Hughes 
et al., 1992), suggesting a conserved role for vasopressin 
(-related) peptides in the modulation of insulin (-related 
peptide) release in both mammals  and molluscs. 
In conclusion, we have cloned a novel member of the 
vasopressin/oxytocin receptor family that shares struc- 
tural and signal transduction characteristics with both va- 
sopressin and oxytocin receptors and mediates vasopres- 
sin- as well as oxytocin-like functions of Lys-conopressin. 
These findings indicate that LSCPR may represent an an- 
cestral receptor to both vasopressin and oxytocin recep- 
tors. However, LSCPR does not display nondiscriminative 
binding properties with respect to the amino acid residue 
at position 8 in the ligand, which functionally distinguishes 
vasopressin from oxytocin. Studies of Lys-conopressin re- 
ceptor diversity and the possible existence of nondiscrimi- 
native receptors may further contribute to our understand- 
ing of the historic development of determinants that 
specify pept ide-receptor interactions in the vasopressin/ 
oxytocin superfamily of peptides and their cognate re- 
ceptors. 
Experimental Procedures 
Animals and Peptides 
Adult specimens of L. stagnalis (shell height 28-34 mm), bred in the 
laboratory under standard conditions, were used. Arg-vasopressin, 
Arg-vasotocin, Lys-vasotocin, oxytocin, mesotocin, and isotocin were 
obtained from Saxon Biochemicals (Hannover, Germany). Lys-conopres- 
sin and Arg-conop ressin were obtained from Bachem Feinchemikalien 
AG (Budendorf, Switzerland). ile-conopressin was synthesized as de- 
scribed (Van Kesteren et al., 1995). 
Cloning and Sequencing of LSCPR 
Poly(A) ÷ RNA was isolated from dissected vas deferens of L. stagnalis 
and reverse transcribed into oligo(dT17)-primed cDNA using 200 U of 
M-MLV reverse transcriptase (GIBCO-BRL). Two degenerate oligo- 
nucleotides, TM6s (5'-GGGAATTCG(GT)N(AG)(CT)NTT(CT)N(CT)N 
(ACT)TNTG(CT)TGGN(CT)NCC-3'), directed to a conserved region in 
TM6 of neuropeptide receptors in general, and TM7as (5'-CCGGAT- 
CC(AG)TA(AGT)ATCCANGG(AG)TT(AG)CA(AG)C-3'), directed to a 
conserved region in TM7 of vasopressin and oxytocin receptors, were 
used to amplify vasopressin and oxytocin receptor-like sequences. 
The primers contained at the 5' end a recognition sequence for the 
restriction endonucleases EcoRI and BamHI, respectively. PCR was 
performed in a 100 ~1 solution containing ten animal equivalents of 
vas deferens cDNA, each of the four deoxynucleotides (at 200 I~M), 
150 pmol of each of the primers TM6s and TM7as, 10 mM Tris-HCI 
(pH 8.4), 0.1 mg/ml gelatin, 50 mM KCI, 1.5 mM MgCI2, and 2.5 U of 
Taq DNA polymerase (Perkin-Elmer Cetus). The PCR mixture was 
overlaid with 70 I~1 of mineral oil and incubated in a DNA thermal cycler 
(Perkin-Elmer Cetus) for 50 cycles of 1 rain at 94°C, 1 min at 50°C, 
and 1 min at 72°C. Amplified cDNA fragments were digested with 
EcoRI and BamHI and separated on agarose gel. Fragments of the 
expected size were isolated, cloned into pBluescript (Stratagene), and 
sequenced. One fragment was used to screen several Lymnaea brain- 
specific XZAPII cDNA libraries to obtain a full-length clone. The insert- 
containing pBluescript phagemid corresponding to this clone 
(pBSCPR) was rescued by in vivo excision and sequenced. 
Functional Expression of LSCPR in Xenopus Oocytes 
The protein-encoding region of pBSCPR was amplified using primers 
directed to the translation initiation and termination sequences of the 
cDNA. At the 5' end, the primers contained a recognition sequence 
for the restriction endonucleases BamHI and EcoRI, respectively. The 
sense primer contained the Kozak consensus sequence for transcrip~ 
tion initiation (CCACCATG; Kozak, 1987) to replace the Lymnaea se- 
quence at this position. Amplification was carried out in a DNA thermal 
cycler using 3 U of Ultma DNA polymerase (Perkin-Elmer Cetus) under 
conditions recommended by the supplier. Reactions were incubated 
for 12 cycles of 15 rain at 94°C, 15 rain at 60°C, and 1.5 rain at 72°C. 
The cDNA fragment was digested with BamHI and EcoRI and ligated 
into pGEMHE (Liman et al., 1992), and 5' capped cRNA was tran- 
scribed in vitro from a 3' end linearized plasmid using 40 U of T7 RNA 
polymerase and Cap-Scribe transcription buffer (Boehringer Mann- 
helm). After phenol extraction and ethanol precipitation, the cRNA was 
dissolved in bidistilled water, and 50 nl ( -3  ng of RNA) was injected 
into Xenopus oocytes. After incubating the injected oocytes for 2-3 
days at 20°C (for details, see Meyerhof et al., 1988), two electrode 
voltage-clamped oocytes were challenged with 1.5 min applications 
of Lys-conopressin and various related peptides. Peptide-induced 
membrane currents were recorded at holding potentials of -50 mV. 
For Lys-conopressin, a dose-response curve was constructed by in- 
tegrating the membrane currents over time and plotting these values 
(expressed as a percentage of the maximal membrane current) semi- 
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logarithmically versus the ligand concentration. The ECs0 value was 
calculated from the mean of three experiments. 
Localization of LSCPR Gene Expression 
Male and female sex organs, kidney, skin, brain, salivary gland, and 
hepatopancreas were dissected, and total RNA was isolated from each 
tissue in triplicate. Equal amounts of RNA (3-5 ~g for each tissue) 
were reverse transcribed into oligo(dT17)-primed cDNA using 200 U 
of M-MLV reverse transcriptase (GIBCO-BRL), and 5% of each reac- 
tion was used directly in a PCR experiment. A sense primer located 
in TM6 (5'-TTGTCCAGATGTGGAGCGCC-3') and an antisense primer 
located just downstream of the stop codon (5'-AGATTCCAAGGGTTC- 
TCAAATGTGACG-3') were used to amplify LSCPR cDNA, and primers 
specific for Lymnaea fructose 1,6-biphosphate aldolase (R. E. V. K., 
unpublished data) were used as a positive control for each cDNA prep- 
aration. After 30 cycles of amplification, PCR products were separated 
on agarose gel, transferred to Hybond N + membrane (Amersham), 
hybridized to 5' end ~2P-labeled primers specific for each product, and 
autoradiographed. 
For in situ hybridization, full-length digoxigenin-labeled runoff anti- 
sense RNA was synthesized from 5' end linearized ptasmid pBSCPR 
and from a plasmid containing the Lys-conopressin cDNA (Van Kest- 
eren et al., 1992), using 20 U of T3 RNA polymerase and digoxigenin- 
UTP labeling mixture (both from Boehringer Mannheim); labeled 
cRNAs were alcohol precipitated. Lymnaea brains were freeze-dried 
at -40°C, fixed with paraformaldehyde vapor (80°C for 1 hr), and 
embedded in paraffin. Sections of 7 p,m were alternately collected on 
poly-L-lysine-coated slides. Before hybridization, slides were pre- 
treated with 0.2% pepsin in 0.2 N HCI at 37°C for 20 min and washed 
in bidistilled water. In situ hybridization was carried out as described 
(Tensen et al., 1991), with the exception that the hybridization buffer 
contained 60% formamide and 2-5 ng/ml cRNA probe. One series of 
sections was incubated with the LSCPR probe, the other with the 
Lys-conopressin probe. Control slides were incubated with sense RNA 
probes. After 16 hr of hybridization at 48°C, slides were washed twice 
in 2x SSC at 20°C, once in 2x SSC containing 0.1 mg/ml RNase 
A at 37°C for 45 min, twice in t x SSC and in 0.5x SSC at 20°C, 
and twice in 0.2 x SSC and in 0.1 x SSC at 60°C. Hybrids were visual- 
ized using an alkaline phosphatase-conjugated anti-digoxigenin anti- 
serum (Beehringer Mannheim). 
Electrophysiological Recordings 
Antibiotic saline was composed of 51.3 mM NaCI, 1.7 mM KCI, 4.1 
mM CaCI2, 1.5 mM MgCI~, 5 mM HEPES (pH 7.9), and 150 p,g/ml 
gentamicin (Sigma). Defined medium consisted of serum-free 50% 
Liebowitz L-15 medium (GIBCO BRL) containing 40.0 mM NaCI, 1.7 
mM KCI, 4.1 mM CaCI2, 1.5 mM MgCI2, 10.0 mM HEPES (pH 8.1), 
150 p.g/ml L-glutarnine, 54 p.g/ml D-glucose, and 25 p.g/ml gentamicin 
(for details, see Ridgway et al., 1991). Dissected anterior and posterior 
vas deferens was cut into pieces, washed 4 times for 10 rain in antibiotic 
saline, and incubated at 37°C for 2 hr in defined medium containing 
0.3% coll~genase/dispase (Sigma). Cells were centrifuged at 600 x 
g for 10 r~in and washed 3 times in antibiotic saline. After removal of 
large debris, cells were resuspended in defined medium, transferred 
to poly-L-lysine-coated Falcon 3001 culture dishes, and stored at 4°C 
for 20 hr. Light green cells were isolated and cultured as described 
(Kits et al., 1991). Cells in the anterior lobe of the right cerebral ganglion 
were recorded in situ in the isolated nervous system. 
Isolated cells and nervous systems were bathed in HEPES-buffered 
saline composed of 30 mM NaCI, 10 mM NaCH3SO4, 4 mM CaCI2, 
1.5 mM MgCI2, 1.7 mM KCI, 5 mM NaHCO3, 10 mM HEPES (pH 7.8, 
adjusted with NaOH). Standard pipette saline used in whole-cell volt- 
age-clamp recordings was composed of 29 mM KCI, 2.3 mM CaCI2, 
2 mM Mg-ATP, 0,1 mM Tris-GTP, 11 mM EGTA, 10 mM HEPES (pH 
7.4, adjusted with KOH). Ca 2+ currents were recorded after HEPES- 
buffered satine was replaced by 40 mM tetraethylammonium (TEA) 
chloride, 4 mM CaCI2, 2 mM MgCt2, 2 mM 4-aminopyridine, 10 mM 
HEPES (pH 7.8, adjusted with TEA-OH) under continuous perfusion. 
The pipette solution used in the Ca 2+ current recordings was composed 
of 29 mM CsCI, 2,3 mM CaCI2, 2 mM Mg-ATP, 0.1 mM Tris-GTP, 11 
mM EGTA, 10 mM HEPES (pH 7.4, adjusted with CsOH). Lys- 
conopressin was applied by means of a pressure ejection system 
through a small glass pipette ( - 20 t~m tip diameter) placed - 100 t~m 
from the recorded cell. Effects on current-voltage relations of voltage- 
dependent currents were studied under continuous application of Lys- 
conopressin during a series of depolarizing voltage steps. 
Membrane potential recordings were made using sharp microelec- 
trodes ( -40 M~) filled with 0.5 M KCI and an Axoclamp 2A ampifier 
(Axon Instruments) in the bridge balance mode or a custom-built micro- 
electrode amplifier. Whole-cell voltage-clamp recordings were made 
using the Axoclamp 2A amplifier in the continuous single-electrode 
voltage-clamp mode. Pipettes (2-6 M~) were pulled on a Flaming/ 
Brown P-87 horizontal microelectrode puller (Sutter Instruments) from 
Clark GC-150T glass (Clark Electromedical; seal resistance >1 G~). 
After disrupture of the patch membrane, series resistance (typically 
<5 M~) was compensated for - 70% using the bridge balance control 
of the amplifier. Cell capacitance (-100 pF) was not compensated. 
To allow equilibration of the interior of the cell with the pipette solution, 
Ca 2+ current measurements were only started about 20 min after get- 
ting access to the cell. 
Data acquisition was controlled using a CED 1401 AD/DA converter 
(Cambridge Electronics Design) connected to an Intel 80486-based 
computer un with voltage-clamp software developed in our laboratory. 
The current recordings were filtered at 1-5 kHz, sampled at 1 kHz, 
and stored on-line. This system allowed simultaneous application of 
voltage steps, acquisition of current recordings, and timed application 
of Lys-conopressin. 
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